Life Sciences Industry Report 2025 PART 1
In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical industry along in 2024.
With 2025 here, and in the midst of life sciences’ technological renaissance, this selection of multimedia content provides a pharma market overview in the US and Europe, including standout content from experts across the industry, that touches upon GLP-1s beyond the obesity space, as well as AI, digital health, oncology, rare disease, and biosimilars and generics.
Through multimedia content, industry analysis, and expert interviews we pull back the curtain on some of the key trends set to influence innovation over the coming year. From the weight loss gold rush of GLP-1s and the impact of GenAI on speed to market in pharmaceuticals to understanding PDURS and working through declining HCP access and identifying the future landscape for clinical trials and small and large molecule, these insights, backed by EVERSANA's proprietary data analytics, provide a comprehensive overview of the complex landscape of modern healthcare.
In short, our Life Sciences Industry Report 2025 aims to provide truly informed insight into an industry very much at the height of its discovery and development capabilities, on the precipice of truly impressive, paradigm shifting innovation and, vitally, paving the way to broader access to treatments that will permit better quality of life and patient outcomes overall.
Download now to access exclusive data, expert analysis, and strategic foresight that will drive your success in 2025 and beyond.
